Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM-Reference-Cited by-同舟云学术

Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM

Published:2010-07 Issue:7 Volume:34 Page:864-870
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Rose Christian,Brechignac Sabine,Vassilief Dominique,Pascal Laurent,Stamatoullas Aspasia,Guerci Agnes,Larbaa Dalila,Dreyfus François,Beyne-Rauzy Odile,Chaury Marie Pierre,Roy Lydie,Cheze Stephane,Morel Pierre,Fenaux Pierre

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference45 articles.

1. Proposals for the classification of the myelodysplastic syndromes;Bennett;Br J Haematol,1982

2. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997;Harris;Mod Pathol,2000

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making;Malcovati;J Clin Oncol,2005

5. Porta MGD, Kuendgen A, Malcovati L, Zipperer E, Pascutto C, Travaglino E, et al. Myelodysplastic syndrome (MDS)-specific comorbidity index for predicting the impact of extra-hematological comorbidities on survival of patients with MDS. (abs2677). Blood; 2008:112a.

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment characteristics and outcomes in lower-risk, non-del(5q) myelodysplastic syndromes: findings from a medical record review in the USA, Canada and Europe;Future Oncology;2024-08-14

2. The Role of Hepcidin in Myelodysplastic Syndromes (MDS): A Systematic Review of Observational Studies;Cancers;2024-01-11

3. Transfusions et chélation du fer dans les syndromes myélodysplasiques;Bulletin du Cancer;2023-11

4. How I treat myelodysplastic syndromes;HEMATOLOGIE;2023

5. Lower‐risk myelodysplastic syndromes: Current treatment options for anemia;eJHaem;2022-08-12